Jinxin Fertility Group Limited Just Beat EPS By 33%: Here's What Analysts Think Will Happen Next
It's been a good week for Jinxin Fertility Group Limited (HKG:1951) shareholders, because the company has just released its latest half-yearly results, and the shares gained 8.7% to HK$2.26. Revenues were CN¥1.4b, approximately in line with whatthe analysts expected, although statutory earnings per share (EPS) crushed expectations, coming in at CN¥0.04, an impressive 33% ahead of estimates. Earnings are an important time for investors, as they can track a company's performance, look at what the analysts are forecasting for next year, and see if there's been a change in sentiment towards the company. So we gathered the latest post-earnings forecasts to see what estimates suggest is in store for next year.
Taking into account the latest results, the consensus forecast from Jinxin Fertility Group's 14 analysts is for revenues of CN¥2.85b in 2026. This reflects a reasonable 4.3% improvement in revenue compared to the last 12 months. Per-share earnings are expected to increase 9.0% to CN¥0.071. In the lead-up to this report, the analysts had been modelling revenues of CN¥2.85b and earnings per share (EPS) of CN¥0.067 in 2026. The analysts seems to have become more bullish on the business, judging by their new earnings per share estimates.
See our latest analysis for Jinxin Fertility Group
There's been no major changes to the consensus price target of HK$3.18, suggesting that the improved earnings per share outlook is not enough to have a long-term positive impact on the stock's valuation. That's not the only conclusion we can draw from this data however, as some investors also like to consider the spread in estimates when evaluating analyst price targets. There are some variant perceptions on Jinxin Fertility Group, with the most bullish analyst valuing it at HK$4.64 and the most bearish at HK$2.20 per share. This is a fairly broad spread of estimates, suggesting that analysts are forecasting a wide range of possible outcomes for the business.
Looking at the bigger picture now, one of the ways we can make sense of these forecasts is to see how they measure up against both past performance and industry growth estimates. The period to the end of 2026 brings more of the same, according to the analysts, with revenue forecast to display 8.8% growth on an annualised basis. That is in line with its 8.3% annual growth over the past five years. By contrast, our data suggests that other companies (with analyst coverage) in a similar industry are forecast to see their revenues grow 4.6% per year. So it's pretty clear that Jinxin Fertility Group is forecast to grow substantially faster than its industry.
The Bottom Line
The biggest takeaway for us is the consensus earnings per share upgrade, which suggests a clear improvement in sentiment around Jinxin Fertility Group's earnings potential next year. Happily, there were no major changes to revenue forecasts, with the business still expected to grow faster than the wider industry. The consensus price target held steady at HK$3.18, with the latest estimates not enough to have an impact on their price targets.
With that in mind, we wouldn't be too quick to come to a conclusion on Jinxin Fertility Group. Long-term earnings power is much more important than next year's profits. We have forecasts for Jinxin Fertility Group going out to 2028, and you can see them free on our platform here.
Even so, be aware that Jinxin Fertility Group is showing 1 warning sign in our investment analysis , you should know about...
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.